Prosus

PRX · Euronext Amsterdam · EUR

€34.50Change from previous close: −0.90%Absolute change: −€0.31

Close · October 2, 2026

At a glance

Revenue growth
+57.29%
FY to Mar 2026 vs FY to Mar 2025
Net income growth
−5.89%
FY to Mar 2026 vs FY to Mar 2025
Net margin
119.9%
FY to Mar 2025: 200.4%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Cash flow · Annual
ItemFY to Mar 2026FY to Mar 2025FY to Mar 2024FY to Mar 2023FY to Mar 2022
Operating cash flow1,6091,9201,045-120-605
Depreciation and amortization390119159158168
Capital expenditure-98.0-83.0-42.0-229-212
Investing cash flow6,79411,87520912,6434,392
Financing cash flow-8,860-8,739-8,116-12,4512,403
Dividends paid-508-268-199-191-238
Share repurchases-7,410-8,420-7,277-10,516-4,995
Debt issued1,12011059.01049,564
Debt repaid-1,977-91.0-159-107-1,670
Effect of exchange rates-18.0-95.0-165-69.0-124
Net change in cash-4574,914-7,377-91.06,066
Free cash flow1,5111,8371,003-349-817
Levered free cash flow847662-424-1,679-946